These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35747599)
1. Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report. Liu R; Luo H; Zhang Q; Sun S; Liu Z; Wang X; Geng Y; Zhao X Mol Clin Oncol; 2022 Jul; 17(1):114. PubMed ID: 35747599 [TBL] [Abstract][Full Text] [Related]
2. Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases. Miyatake S; Furuse M; Kawabata S; Maruyama T; Kumabe T; Kuroiwa T; Ono K Neuro Oncol; 2013 Jun; 15(6):650-5. PubMed ID: 23460324 [TBL] [Abstract][Full Text] [Related]
3. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain. Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851 [TBL] [Abstract][Full Text] [Related]
4. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial. Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830 [TBL] [Abstract][Full Text] [Related]
5. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis. Khan M; Zhao Z; Arooj S; Liao G BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308 [TBL] [Abstract][Full Text] [Related]
7. Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study. Boström JP; Seifert M; Greschus S; Schäfer N; Glas M; Lammering G; Herrlinger U Strahlenther Onkol; 2014 Apr; 190(4):416-21. PubMed ID: 24429478 [TBL] [Abstract][Full Text] [Related]
8. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis. Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276 [TBL] [Abstract][Full Text] [Related]
9. Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases. Weng Y; Shen J; Zhang L; Fang Z; Xiao F; Zhang C; Fan Z; Huang K; Wang L; Huang B; Wu F; Zhang T; Xu Q Front Surg; 2021; 8():720506. PubMed ID: 34540887 [TBL] [Abstract][Full Text] [Related]
10. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264 [TBL] [Abstract][Full Text] [Related]
11. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience. Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286 [TBL] [Abstract][Full Text] [Related]
12. Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial. Xu Y; Rong X; Hu W; Huang X; Li Y; Zheng D; Cai Z; Zuo Z; Tang Y Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1087-1095. PubMed ID: 29885994 [TBL] [Abstract][Full Text] [Related]
13. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases. Glitza IC; Guha-Thakurta N; D'Souza NM; Amaria RN; McGovern SL; Rao G; Li J Melanoma Res; 2017 Dec; 27(6):580-584. PubMed ID: 28817446 [TBL] [Abstract][Full Text] [Related]
14. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study. Xue R; Chen M; Cai J; Deng Z; Pan D; Liu X; Li Y; Rong X; Li H; Xu Y; Shen Q; Tang Y Front Oncol; 2021; 11():720417. PubMed ID: 34692494 [TBL] [Abstract][Full Text] [Related]
15. Bevacizumab Combined with Corticosteroids Does Not Improve the Clinical Outcome of Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis. Li H; Rong X; Hu W; Yang Y; Lei M; Wen W; Yue Z; Huang X; Chua MLK; Li Y; Cai J; He L; Pan D; Cheng J; Pi Y; Xue R; Xu Y; Tang Y Front Oncol; 2021; 11():746941. PubMed ID: 34650930 [TBL] [Abstract][Full Text] [Related]
16. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts. Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015 [TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Bevacizumab in Radionecrosis After Radiosurgery of a Single Brain Metastasis. Delishaj D; Ursino S; Pasqualetti F; Pesaresi I; Desideri I; Cosottini M; Laliscia C; Paiar F; Fabrini MG Rare Tumors; 2015 Dec; 7(4):6018. PubMed ID: 26788278 [TBL] [Abstract][Full Text] [Related]
19. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802 [TBL] [Abstract][Full Text] [Related]
20. Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience. Lee SH; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI J Korean Neurosurg Soc; 2023 Sep; 66(5):562-572. PubMed ID: 36642947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]